The Manufacturers Life Insurance Company Has $54.82 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

The Manufacturers Life Insurance Company trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH) by 0.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,751,408 shares of the company’s stock after selling 7,653 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Option Care Health were worth $54,819,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in OPCH. UMB Bank n.a. grew its holdings in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. International Assets Investment Management LLC grew its holdings in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Option Care Health stock opened at $23.76 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $4.04 billion, a PE ratio of 19.97, a P/E/G ratio of 2.42 and a beta of 1.32. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The stock has a 50-day moving average price of $27.00 and a two-hundred day moving average price of $28.93.

Analyst Ratings Changes

OPCH has been the topic of several analyst reports. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research dropped their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Truist Financial dropped their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.